2022 SPONSORS & EXHIBITORS
We would like to thank the following sponsors and exhibitors for their support of the Communicable Diseases & Immunisation Conference 2022.
Office of Health Protection and Response, Australian Government Department of Health
Dr Ben Polkinghorne, Director, Communicable Disease Epidemiology and Surveillance Section
A: MDP 14 PO Box 9848, Canberra ACT 2601
T: 02 6289 5170
The mission of the Office of Health Protection and Response, in partnership with key stakeholders, is to protect the health of the Australian community through effective national leadership, coordination and regulation; and by building and sustaining the capacity and capability to prevent, prepare and respond to threats and risks to public health and safety arising from communicable diseases, natural disasters, acts of terrorism and other incidents.
Pfizer Australia Pty Ltd
Stephanie Moses, Senior Brand Manager, Vaccines
A: Level 15-18, 151 Clarence Street, Sydney NSW 2000
T: 02 9850 3333
Breakthroughs that change patients’ lives™
Throughout Pfizer's 170 year history, and over 60 years in Australia, we have remained dedicated to discovering and developing new and better ways to prevent and treat disease, and improve the health and wellbeing of people around the world.
At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines. Our diversified global health care portfolio includes human biologic and small molecule medicines and vaccines, as well as many of the world’s best-known consumer products.
For more information visit www.pfizer.com.au
Leonie Loyer, Director, Government & In-Licensed Vaccines
A: Tower One, Collins Square, 727 Collins Street, Melbourne, Vic 3008.
T: 0434 608 564
Seqirus, a CSL company, is a leading provider of essential vaccines and pharmaceuticals. We have served Australia’s healthcare needs for over a century and today we operate Australia’s only local manufacturing facility for seasonal and pandemic influenza vaccine. Seqirus produces a range of unique medicines in the National Interest, and also in-licences a broad range of paediatric and adult vaccines and specialty pharmaceutical products.
Novavax, Inc & Biocelect
Crissa Kyriazis, General Manager
A: Suite 502, 139 Macquarie St, Sydney, NSW 2095
T: 0413 845 786
Novavax is a US-based biotechnology company focused on the development of innovative vaccines that leverage our proprietary recombinant nanoparticle technology that may help prevent many infectious diseases. Our platform has the potential to produce highly immunogenic antigens, enabling the production of vaccines to respond to known and emerging disease threats.
Biocelect Pty Ltd is a privately owned, full-service Australian pharmaceutical company working with local and overseas partners to bring critical pharmaceutical products and medical technology solutions to the Australian market. Our priority areas include infectious diseases, specialty care and in-vitro diagnostics. In 2020, Biocelect was appointed the Australian and New Zealand sponsor for the Novavax COVID-19 Vaccine. We are proud to play an important part in our Governments’ COVID-19 management plans
Birgit Beisner, Head, NIP Vaccines Business
A: Level 3, 436 Johnston Street, Abbotsford VIC 3067
T: 03 9721 6000
GSK is a science-led global healthcare company with a special purpose: to help people do more, feel better and live longer. In Australia, we offer a broad portfolio of innovative and established vaccines and medicines in respiratory disease, HIV and oncology.
Our vaccines have been at the heart of the Australian National Immunisation Program from the time it began, helping to protect infants and children from multiple serious diseases. Beyond childhood, our vaccines help to protect Australians throughout life whether at home or travelling overseas.
In 2020 we invested over $9 billion in research and development globally, focusing on science related to the immune system, human genetics and advanced technologies.
For more information visit au.gsk.com.
Anne-Marie Grundling, Commercial Manager - Government
A: 12-24 Talavera Rd, Macquarie Park, NSW 2113
T: 04488 22294
Sanofi are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the centre of our ambitions.
Byron Nyin, Senior Brand Manager
A: 66 Talavera Road, Macquarie Park, NSW 2113
T: 0422 994 429
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in four therapy areas - Respiratory & Autoimmunity, Cardiovascular & Metabolic Disease, Oncology & Vaccines & Immune Therapies.
AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information, please visit: www.astrazeneca.com.au
Welcome Reception Sponsor and International Speaker Sponsor
Moderna’s Mission is to deliver on the promise of mRNA science to create a new generation of transformative medicines for patients. The company was founded in 2010, focused on building the leading mRNA technology platform, infrastructure to accelerate drug discovery and early development, a rapidly expanding pipeline, and a world-class team. Our pipeline includes development candidates for mRNA-based vaccines and therapies spanning several therapeutic areas, with multiple clinical trials underway and other development candidates progressing toward the clinic. In addition, there are numerous discovery programs advancing toward development.
The Peter Doherty Institute for Infection and Immunity
Jennifer Fagundes, Operations and Projects Coordinator
A: 792 Elizabeth St, Melbourne VIC 3000
T: 8344 6564
Finding solutions to prevent, treat and cure infectious diseases and understanding the complexities of microbes and the immune system requires innovative approaches and concentrated effort. This is why the University of Melbourne – a world leader in education, teaching and research excellence – and The Royal Melbourne Hospital – an internationally renowned institution providing outstanding care, research and learning – partnered to create the Peter Doherty Institute for Infection and Immunity (Doherty Institute); a centre of excellence where leading scientists and clinicians collaborate to improve human health globally.
National Centre for Immunisation Research & Surveillance (NCIRS)
Katie Sultana, Communication Officer
A: Locked Bag 4001, Westmead NSW 2145
The National Centre for Immunisation Research and Surveillance (NCIRS) provides objective expert advice on all aspects of immunisation and vaccine preventable diseases to inform policy and planning for immunisation services in Australia and across our region
NCIRS is a collaborative team of experts in public health, biostatistics, infectious diseases, paediatrics, internal medicine, epidemiology, communication, social science and quantitative and qualitative research and survey methods.
University of Tasmania
Nicola Stephens, Associate Professor of Public Health
A: Private Bag 34, Hobart TAS 7000
T: 1300 363 864
With the COVID-19 pandemic elevating public health to the forefront of public interest, the University of Tasmania’s Public Health program will provide you with the skills necessary to tackle contemporary and emerging public health challenges.
With our Master of Public Health, you’ll learn to be a systems thinker and confidently navigate the research policy- practice interface. You will have the skills to design, implement, and evaluate complex evidence-based policy and practice interventions in local and global contexts. Find out more about our suite of postgraduate courses at utas.edu.au.
At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we've been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world's most challenging diseases.